6533b838fe1ef96bd12a3aa2

RESEARCH PRODUCT

Cuantificación de la fibrosis hepática mediante biomarcadores de imagen

Annalisa BerzigottiDavid Martí-aguadoLuis Martí-bonmatíM França

subject

education.field_of_studymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryLiver fibrosisPopulationMagnetic resonance imagingContext (language use)medicine.disease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFibrosisLiver biopsyClinical valuemedicine030211 gastroenterology & hepatologyRadiology Nuclear Medicine and imagingeducationIntensive care medicinebusinessReference standards

description

There is a need for early identification of patients with chronic liver diseases due to their increasing prevalence and morbidity-mortality. The degree of liver fibrosis determines the prognosis and therapeutic options in this population. Liver biopsy represents the reference standard for fibrosis staging. However, given its limitations and complications, different non-invasive methods have been developed recently for the in vivo quantification of fibrosis. Due to their precision and reliability, biomarkers' measurements derived from Ultrasound and Magnetic Resonance stand out. This article reviews the different acquisition techniques and image processing methods currently used in the evaluation of liver fibrosis, focusing on their diagnostic performance, applicability and clinical value. In order to properly interpret their results in the appropriate clinical context, it seems necessary to understand the techniques and their quality parameters, the standardization and validation of the measurement units and the quality control of the methodological problems.

https://doi.org/10.1016/j.rx.2017.09.003